Dana Foundation David Mahoney Neuroimaging Program RFP

Monday, January 23, 2017 - Monday, February 06, 2017
The Dana Foundation’s Neuroimaging research program focuses on improving human brain and brain-immune functioning to promote health, and prevent and treat disease. Funds support pilot-testing by investigators, who are early in their research careers, to enable them to pursue promising, high-risk, and innovative ideas that have a direct clinical application. The pilot data are anticipated to help increase competitiveness for seeking larger-scale support from other funders. Grant amounts for each study may be up to $200,000 total, payable over three years. Applicants will be informed within eight weeks of the preliminary proposal deadline on whether they are invited to prepare full proposals. The first awards will be announced in September 2017. Subsequent award announcements will be made in December 2017.


The Beautiful Brain: The Drawings of Santiago Ramón y Cajal

Weisman Art Museum
Minneapolis, MN
Saturday, January 28, 2017 - Sunday, May 21, 2017
This traveling exhibition of Cajal’s original drawings was organized by the Weisman Art Museum in collaboration with Drs. Eric Newman, Alfonso Araque, and Janet Dubinsky, neuroscientists at the University of Minnesota. The exhibit is organized in collaboration with Dr. Ricardo Martinez Murillo, neuroscientist and curator of the Cajal Legacy at the Cajal Institute (CSIC) in Spain. Eighty of Cajal’s drawings, many appearing for the first time in the United States, will be accompanied by a selection of contemporary visualizations of the brain, photographs, historic books, and scientific tools. After the debut at Weisman Art Museum, the exhibition will travel to university galleries and museums, throughout the United States and Canada.


Neurophilosophy and the Origin of Moral Practices

University of Pennsylvania
Philadelphia, PA
Thursday, February 02, 2017
Patricia Churchland, D.Litt, B.Phil, LLD, was an early proponent of the mutual relevance of neuroscience and philosophy. In her own work she has used developments in neuroscience to clarify philosophical issues concerning consciousness, the self, free will, decision making and ethics, among other topics. In recent years she has explored the nature of morality in her award-winning book, Braintrust, and most recently she has turned her attention to issues of personal identity and spirituality in the book Touching a Nerve: the Self as Brain, of which the New York Times wrote: "It is hard to conceive of a better guide to this difficult terrain than the MacArthur-award-winning Ms. Churchland...[She] writes with surpassing clarity, elegance, humor and modesty." Professor Churchland has spent the last three decades at the University of California, San Diego, where she served as the UC President's Professor of Philosophy.


The Deeper Self: An Expanded View of Consciousness

The New York Academy of Sciences
New York, NY
Wednesday, February 15, 2017
As science continues to explore the mysteries of the unconscious, two critical questions remain: first, can unconscious impulses, desires, and feelings be willfully raised to the level of the conscious self? Second, can we methodically tap into the unconscious to gear ourselves along more creative lines?  Neuroscientist David Eagleman, writer Siri Hustvedt, historian of psychology Sonu Shamdasani, and neuropsychologist Mark Solms will tackle everything from noetic experiences and the role of intuition to the phenomenon of peak experience and Jung's "collective unconscious."


Neuroscience and the Law

Baruch College
New York, NY
Thursday, March 09, 2017
In the past decades, cognitive neuroscience has enabled a more complex study of how brain processes relate to mental states. The law interprets mental states, particularly intentions, to determine whether a person will live freely or in the custody of the state. Is cognitive neuroscience ready to help the law interpret human intentions – and, if so, how? Join U. S. District Judge for the Southern District of New York and frequent contributor to The New York Review of Books Jed S. Rakoff, and Baruch Professor and Neuroscientist Jennifer Mangels, PhD, for a discussion on whether the significant advances in our knowledge of the brain warrant their application to the law.


Brainwave: How to Perceive Without Sight

The Rubin Museum of Art
New York, NY
Saturday, March 18, 2017
Isaac Lidsky knows better than most how the brain confronts new challenges. He went from childhood actor, to Harvard Law graduate, to successful entrepreneur. He also began to go blind at age thirteen, eventually losing his sight entirely by the time he was twenty-five. With neuroscientist Michael E. Goldberg, he discusses how the brain overcomes limitations and how perception goes beyond the visual.


BNA2017 Festival of Neuroscience

British Neuroscience Association
Birmingham, UK
Monday, April 10, 2017 - Thursday, April 13, 2017
The BNA’s flagship biennial meeting is one of the largest international meetings of its kind throughout Europe in 2017.


13th International Conference on Myasthenia Gravis and Related Disorders

The New York Academy of Sciences
New York, NY
Monday, May 15, 2017 - Wednesday, May 17, 2017
The conference will provide a forum for basic scientists and clinical researchers to discuss, disseminate, and highlight the advances and challenges of therapies for myasthenia gravis. The goals of this program are to: 1) provide a forum for basic, translational, and clinical researchers from academia and industry to present and discuss the most up-to-date findings in MG research; 2) explore and encourage multidisciplinary and multi-sector collaborations to enhance investigative approaches into MG and related autoimmune and neuromuscular disorders; 3) review current MG therapeutic options, ongoing clinical trials, and challenges and limitations faced in the clinic; and 4) identify knowledge gaps and future directions of research required for further breakthroughs. Ten plenary sessions will span the full spectrum of research from bench to bedside, including structure and function of the neuromuscular junction, advances in immunology, recent clinical developments related to MG, outcome measurements, clinical trial development, animal models of neuromuscular disease, MG treatment updates, congenital and Lambert-Eaton myasthenic syndromes, thymectomy, and the MGTX trial.